The Triple Combination Indinavir-Zidovudine-Lamivudine Is Highly Synergistic
Administration of the combination of indinavir-zidovudine-lamivudine has been demonstrated to cause a large fraction of treated patients to have a decline in human immunodeficiency virus type 1 (HIV-1) copy number to below the detectability of sensitive assays. A recent investigation (G. L. Drusano,...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2000
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89812/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10722511/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.4.1051-1058.2000 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
